860575P

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0)

Avanti Research^™ - A Croda Brand 860575P, powder

• 동의어(들): D-lactosyl-β1-1′-N-octanoyl-L-threo-sphingosine
• 실험식(Hill 표기법): C₃₈H₇₁NO₁₃
• CAS Number: 939036-94-9
• Molecular Weight: 749.97
• MDL number: MFCD28143570
• UNSPSC 코드: 12352211
• NACRES: NA.25

속성

• 양식: powder
• 포장: pkg of 1 × 1 mg (860575P-1mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand 860575P
• 지질 유형: sphingolipids
• 배송 상태: dry ice
• 저장 온도: −20°C
• SMILES string: CCCCCCCCCCCCC/C=C/[C@@](O)([H])[C@@]([H])(NC(CCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O[C@H](O2)[C@H](O)[C@@H](O)[C@H]([C@H]2CO)O
• InChI key: JUCWRRXMPGRQOG-CKTHHAJGSA-N

설명

일반 설명

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) is a synthetic glycosphingolipid (GSL) with nonnatural stereochemistry.

애플리케이션

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) may be used to disrupt brain-derived neurotropic factor (BDNF)-induced integrin clustering.

생화학적/생리학적 작용

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) is a caveolar uptake inhibitor, which blocks SV40 virus infection. It also prevents E1-integrin activation and downstream signaling. C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) can deter the aggregation of lipids and proteins into glycosphingolipids (GSLs) and cholesterol-enriched microdomains (rafts) at the plasma membrane (PM).

포장

5 mL Amber Glass Screw Cap Vial (860575P-1mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3